Tim Scott actually said...

how do we make the conversation more important, and, frankly, how do we make the information more readily available.

We are in desperate need for cures for these two chronic conditions.

I continue to feel as if there's a serious risk in not providing notice that a product is a biosimilar.

We can do this, and that would enable people to develop new therapies at a much lower cost, but with better information about safety and eff...